Molecular Medicine Research Center, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist, 333, Taoyuan City, Taiwan, Republic of China.
Department of Otolaryngology-Head & Neck Surgery, Chang Gung Memorial Hospital at Linkou, 33305, Gueishan, Taoyuan, Taiwan.
Cell Death Dis. 2020 Sep 3;11(9):721. doi: 10.1038/s41419-020-02927-7.
High-level expression of ASC (Apoptosis-associated speck-like protein containing a CARD) leads to lymph node metastasis in OSCC, but the underlying mechanism remains unclear. Here, we show that HIF-1α participates in ASC-induced metastasis. We identified 195 cell-motion-associated genes that were highly activated in ASC-overexpressed SAS_ASC cells; of them, 14 representative genes were found to be overexpressed in OSCC tissues in our previously reported RNA-seq dataset, OSCC-Taiwan. Nine of the 14 genes were also upregulated in OSCC-TCGA samples. Among the nine genes, RRAS2, PDGFA, and VEGFA, were correlated with poor overall survival of patients in OSCC-TCGA dataset. We further demonstrated that the promoters of these 14 ASC-induced genes contained binding motifs for the transcription-regulating factor, HIF-1α. We observed that ASC interacted with and stabilized HIF-1α in both the cytoplasm and the nucleus under normoxia. Molecules involved in the HIF-1α pathway, such as VHL and PHD2, showed no difference in their gene and protein levels in the presence or absence of ASC, but the expression of HIF-1α-OH, and the ubiquitination of HIF-1α were both decreased in SAS_ASC cells versus SAS_con cells. The migration and invasion activities of SAS_ASC cells were reduced when cells were treated with the HIF-1α synthesis inhibitor, digoxin. Taken together, our results demonstrate that the novel ASC-HIF-1α regulatory pathway contributes to lymph node metastasis in OSCC, potentially suggesting a new treatment strategy for OSCC.
高表达 ASC(含 CARD 的凋亡相关斑点样蛋白)可导致 OSCC 淋巴结转移,但潜在机制尚不清楚。在这里,我们表明 HIF-1α 参与 ASC 诱导的转移。我们鉴定了 195 个与细胞运动相关的基因,这些基因在 ASC 过表达的 SAS_ASC 细胞中高度激活;在我们之前报道的 RNA-seq 数据集 OSCC-Taiwan 中,其中 14 个代表性基因在 OSCC 组织中过表达。这 14 个基因中的 9 个在 OSCC-TCGA 样本中也上调。在这 9 个基因中,RRAS2、PDGFA 和 VEGFA 与 OSCC-TCGA 数据集患者的总体生存率差相关。我们进一步证明,这 14 个 ASC 诱导基因的启动子包含转录调节因子 HIF-1α 的结合基序。我们观察到,在常氧条件下,ASC 在细胞质和细胞核中与 HIF-1α 相互作用并稳定 HIF-1α。在存在或不存在 ASC 的情况下,HIF-1α 途径中的分子,如 VHL 和 PHD2,其基因和蛋白水平没有差异,但在 SAS_ASC 细胞中,HIF-1α-OH 的表达和 HIF-1α 的泛素化均降低与 SAS_con 细胞相比。当用 HIF-1α 合成抑制剂地高辛处理 SAS_ASC 细胞时,细胞的迁移和侵袭活性降低。总之,我们的结果表明,新型 ASC-HIF-1α 调节途径有助于 OSCC 的淋巴结转移,可能为 OSCC 提供一种新的治疗策略。